ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 2115

Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study

Neil Binkley1, Michele McDermott2, Eric Yeh2, Joseph Lane3, Jolenta Cheung4, Mona Amet4 and Felicia Cosman5, 1University of Wisconsin, Madison, 2Amgen Inc., Thousand Oaks, 3Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 4Adelphi Real World, Bollington, United Kingdom, 5Columbia University, College of Physicians and Surgeons, New York, NY

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Fracture, osteoporosis, pain, quality of life

Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: To characterize pain status (frequency, severity, persistency) and effect on activities of daily living (ADLs) in patients with symptomatic vertebral fractures (VF).

Methods: This was an observational, cross-sectional, survey of patients age ≥50 years with ≥1 symptomatic osteoporotic VF within the last 36 weeks (wks) confirmed by spine imaging, recruited from July 2022 to August 2023 at 7 clinical sites across the United States. Data were collected through a one-time patient survey and retrospective medical chart review, and analyzed descriptively. Patients described their pain level and pain characteristics.

Results: Of the 116 patients enrolled, most were postmenopausal women (83%), white (92%), and ≥60 years of age (95%); 37% of patients were recruited within 12 wks, 40% within >12-24 wks, and 23% within >24-36 wks of having a symptomatic VF. Index VF was confirmed by x-ray (60%), MRI (50%), and/or CT scan (37%).

As shown in Fig 1A, within the first 12 wks of an acute symptomatic VF, pain was reported as constant/steady by 42% of patients. After 12 wks, the proportion who reported constant/steady pain was lower but still more than 20% in patients who had a VF >24-36 wks earlier; at that time, more than 80% of patients reported at least intermittent pain. 44% reported high pain severity (between 7–10) within the first 12 wks following VF, and 30% and 36% reported high severity at >12-24 wks and >24-36 wks, respectively. The most common movements that increased pain were standing up (55%), bending down (53%), and lifting (42%). In general, patients reported a negative impact of VF on various ADL, with housework and walking being most impacted (Fig 1B).

Conclusion: In this cross-sectional study, back pain persisted and affected ADL in the majority of patients after 24 wks. Even >24-36 wks after a VF, 84% of patients experienced constant/steady or periodic/intermittent pain. ADLs that were difficult to complete required movements that patients often reported as precipitating pain. Acknowledging the study limitations of cross-sectional design and small numbers enrolled at different times from VF, particularly in the >24-36-wk group, these data provide insight into the impact of VF on patients and emphasize the importance of VF prevention.

Supporting image 1


Disclosures: N. Binkley: Amgen, 5, GE Healthcare, 5, Radius, 2, 5; M. McDermott: Amgen, 3, 11; E. Yeh: Amgen, 3, 11; J. Lane: Amgen, 1, BIC, 2, Kuros, 2, Lenoss, 1, Merck, 5, Mesentech, 2, Radius Health, 2, 5, UCB, 1; J. Cheung: Adelphi Real World, 3; M. Amet: Adelphi Real World, 3; F. Cosman: Amgen, 2, 5, 6, Biocon, 2, Curateq, 2, Enterabio, 2, Pfizer, 2, Radius Health, 5, 6, UCB, 2.

To cite this abstract in AMA style:

Binkley N, McDermott M, Yeh E, Lane J, Cheung J, Amet M, Cosman F. Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-impact-of-acute-symptomatic-vertebral-fractures-in-the-united-states-an-observational-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-impact-of-acute-symptomatic-vertebral-fractures-in-the-united-states-an-observational-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology